全文获取类型
收费全文 | 3769096篇 |
免费 | 325327篇 |
国内免费 | 15066篇 |
专业分类
耳鼻咽喉 | 52148篇 |
儿科学 | 120369篇 |
妇产科学 | 98504篇 |
基础医学 | 582051篇 |
口腔科学 | 102952篇 |
临床医学 | 347022篇 |
内科学 | 672261篇 |
皮肤病学 | 102323篇 |
神经病学 | 318074篇 |
特种医学 | 148788篇 |
外国民族医学 | 265篇 |
外科学 | 593268篇 |
综合类 | 113738篇 |
现状与发展 | 91篇 |
一般理论 | 2368篇 |
预防医学 | 305954篇 |
眼科学 | 90431篇 |
药学 | 259873篇 |
21篇 | |
中国医学 | 11039篇 |
肿瘤学 | 187949篇 |
出版年
2021年 | 50697篇 |
2020年 | 37732篇 |
2019年 | 59218篇 |
2018年 | 75822篇 |
2017年 | 58274篇 |
2016年 | 64485篇 |
2015年 | 78073篇 |
2014年 | 114975篇 |
2013年 | 180342篇 |
2012年 | 106979篇 |
2011年 | 108948篇 |
2010年 | 125165篇 |
2009年 | 129373篇 |
2008年 | 95524篇 |
2007年 | 99484篇 |
2006年 | 109752篇 |
2005年 | 103667篇 |
2004年 | 104963篇 |
2003年 | 94267篇 |
2002年 | 83413篇 |
2001年 | 136693篇 |
2000年 | 129483篇 |
1999年 | 120634篇 |
1998年 | 64230篇 |
1997年 | 60584篇 |
1996年 | 57936篇 |
1995年 | 58749篇 |
1994年 | 52559篇 |
1993年 | 48760篇 |
1992年 | 84955篇 |
1991年 | 81321篇 |
1990年 | 76864篇 |
1989年 | 75282篇 |
1988年 | 69070篇 |
1987年 | 67304篇 |
1986年 | 63631篇 |
1985年 | 62802篇 |
1984年 | 54707篇 |
1983年 | 49270篇 |
1982年 | 43267篇 |
1981年 | 40611篇 |
1980年 | 38057篇 |
1979年 | 44564篇 |
1978年 | 37964篇 |
1977年 | 34544篇 |
1976年 | 31635篇 |
1975年 | 30519篇 |
1974年 | 32297篇 |
1973年 | 31048篇 |
1972年 | 28996篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
61.
62.
Objective
The aim of the study was to estimate the effect of the state-based reinsurance programs through the section 1332 State Innovation Waivers on health insurance marketplace premiums and insurer participation.Data Source
2015 to 2022 Robert Wood Johnson Foundation Health Insurance Exchange Compare Datasets.Study Design
An event study difference-in-differences (DD) model separately for each year of implementation and a synthetic control method (SCM) are used to estimate year-by-year effects following program implementation.Data Collection/Extraction Methods
Not applicable.Principal Findings
Reinsurance programs were associated with a decline in premiums in the first year of implementation by 10%–13%, 5%–19%, and 11%–17% for bronze, silver, and gold plans (p < 0.05). There is a trend of sustained declines especially for states that implemented their programs in 2019 and 2020. The SCM analyses suggest some effect heterogeneity across states but also premium declines across most states. There is no evidence that reinsurance programs affected insurer participation.Conclusion
State-based reinsurance programs have the potential to improve the affordability of health insurance coverage. However, reinsurance programs do not appear to have had an effect on insurer participation, highlighting the need for policy makers to consider complementary strategies to encourage insurer participation. 相似文献63.
64.
Vilar-Compte Mireya Gaitán-Rossi Pablo Félix-Beltrán Lucía Bustamante Arturo V. 《Journal of immigrant and minority health / Center for Minority Public Health》2022,24(1):65-77
Journal of Immigrant and Minority Health - COVID-19 has disproportionally affected underrepresented minorities (URM) and low-income immigrants in the United States. The aim of the study is to... 相似文献
65.
Timothy J. Cordingley Mark A.G. Wilson Kathryn M. Weston 《Health & social care in the community》2022,30(1):353-359
Vaccination is a vital health care initiative to prevent individual and population infection. To increase vaccination rates the federal government implemented the ‘No Jab, No Pay’ policy, where eligibility for several government benefits required children to be fully vaccinated by removing ‘conscientious objections’ and expanding the age range of children whose families receive benefits. This study assesses the impact of this policy at a local area within a single medical practice community in NSW, Australia. A retrospective clinical audit was performed between 2012 and 2017 on a single general practice's vaccination records for children ≤19 years. Catch-up vaccinations were assessed based on age at vaccination. Incidence of catch-up vaccinations was assessed for each of four years before and two years after the implementation of the ‘No Jab, No Pay’ policy in January 2016, along with the age of children and vaccination(s) given. Catch-up vaccinations were assessed temporally either side of implementation of ‘No Jab, No Pay’. Comparing the average annual vaccination catch-up incidence rate of 6.2% pre-implementation (2012–2015), there was an increase to 9.2% in 2016 (p < .001) and 7.8% in 2017 (p = .027). Secondary outcome measurement of catch-up vaccination incidence rates before (2012–2015) and after (2016–2017) ‘No Jab, No Pay’ implementation showed statistically significant increases for children aged 8–11 years (3.2%–5.6%, p = .038), 12–15 years (7.5%–14.7%, p < .001) and 16–19 years (3.3%–10.2%, p < .001) along with a statistically significant reduction in children aged 1–3 years (11.4%–6.2%, p = .015). Also, catch-up rates for DTPa significantly increased after program implementation. This study demonstrates that the Australian federal government vaccination policy ‘No Jab, No Pay’ was coincident with an increase in catch-up vaccinations within a rural NSW community served by one medical practice, especially for older children. 相似文献
66.
Medicine, Health Care and Philosophy - In this paper, I will provide a phenomenological analysis of somatic obsessions at times present in obsessive–compulsive disorder. I will compare two... 相似文献
67.
Münch F. Purbojo A. Wenzel F. Kohl M. Dittrich S. Rauh M. Zimmermann R. Kwapil N. 《Der Anaesthesist》2022,71(11):882-892
Die Anaesthesiologie - Die Transfusion von Erythrozytenkonzentraten (EK) ist mit verschiedenen Nebenwirkungen assoziiert, die u. a. durch Lagerungsschäden an Erythrozyten hervorgerufen... 相似文献
68.
Alicia C. McDonald PhD MPH Jeremy Gernand PhD Nathaniel R. Geyer DrPH Hongke Wu MD MPH Yanxu Yang MPH Ming Wang PhD 《Cancer》2022,128(9):1832-1839
69.
Robert J. Motzer MD David F. McDermott MD Bernard Escudier MD Mauricio Burotto MD Toni K. Choueiri MD Hans J. Hammers MD PhD Philippe Barthélémy MD PhD Elizabeth R. Plimack MD Camillo Porta MD Saby George MD Thomas Powles MD Frede Donskov MD PhD Howard Gurney MD Christian K. Kollmannsberger MD Marc-Oliver Grimm MD Carlos Barrios MD Yoshihiko Tomita MD PhD Daniel Castellano MD Viktor Grünwald MD PhD Brian I. Rini MD M. Brent McHenry PhD Chung-Wei Lee MD PhD Jennifer McCarthy MA Flavia Ejzykowicz PhD Nizar M. Tannir MD 《Cancer》2022,128(11):2085-2097